From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and infrastructure for therapy commercialization.
Solutions overview
IntegriChain delivers the pharmaceutical industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, and managed services to power their operations and harness the value of their channel, patient and payer data.
View all products
IntegriChain provides a complete set of professional services for commercialization and market access execution–from life science strategy and operational consulting to implementation, integration, migrations, and analytics.
Services overview
We help all stakeholders in the pharmaceutical industry drive access with our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts & pricing, gross-to-net, channel, and patient services – to unlock strategic payer, provider, pharmacy and patient access insights.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, market access experts, analysts, and consulting professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
Careers overview
November 16, 2016
Philadelphia, PA, November 16, 2016 – IntegriChain, a rapidly growing healthcare technology company focused on channel management for life sciences suppliers, today reached a significant business milestone with its 10th anniversary of operations. Started in 2006 by aggregating channel data for an initial handful of pharmaceutical manufacturers, now IntegriChain’s wholesale, retail, and specialty channel data and analytics platform delivers business insights that show pharmaceutical suppliers how patients physically and financially access their healthcare products. On a daily basis, the world’s leading innovators in pharmaceuticals, biopharma and specialty pharmaceuticals, generics, and medtech rely on IntegriChain’s guided analytics to ensure that patients can access products when needed thereby minimizing the chances that patients forego therapy. Today IntegriChain’s platform serves 13 of the top-15 life science companies and more than 50 other suppliers, totaling $200 billion in annual US commerce.
“For ten years, IntegriChain has been the data and analytics foundation underpinning life sciences manufacturer efforts to create more efficient and service-oriented channel models to maximize patient access to critical and often life-changing medical products,” said Kevin Leininger, CEO of IntegriChain. “We are immensely proud of the company we have built through continuous collaboration with our customers to improve and expand our data and guided analytics offerings. Our close bonds within the Greater Philadelphia tech and academic communities and the incredible healthcare tech team that we have developed will advance IntegriChain to our next stage of growth and evolution.”
IntegriChain Milestones IntegriChain was founded by Leininger and Executive Vice President Josh Halpern in November 2006 and launched its data aggregation platform in early 2007 in Princeton, NJ. The company launched its cloud offerings in 2010, followed in 2012 with its channel management application offerings. In 2015, IntegriChain relocated its headquarters to Center City Philadelphia to tap into the city’s rapidly growing healthcare tech human capital market and culture. In early 2016, IntegriChain announced a strategic equity partnership with Accel-KKR, the first tier-one investment in a Philadelphia healthcare tech company by a leading Silicon Valley private equity provider. Last month, IntegriChain announced a strategic partnership with ProMetrics, a leader in longitudinal patient-level data aggregation, to deliver the industry’s first guided analytics solution for specialty channel management, patient service model design, and patient access optimization.
About IntegriChain IntegriChain is a rapidly growing healthcare technology company, offering the leading cloud for channel data aggregation, analytics, and applications for life sciences suppliers to improve patient access. Pharmaceutical, biopharm/specialty pharma, generics, and medtech suppliers leverage insights from IntegriChain’s unmatched visibility to product distribution and demand to optimize product commercialization and to address critical risks throughout the patient journey and product life cycle. IntegriChain delivers wholesale, retail, and specialty channel data and guided analytics for more efficient and service-oriented channel models for mature product categories as well as for innovative products that must balance significant therapeutic benefit with out-of-pocket costs and benefit hurdles. Today IntegriChain is the trusted partner for 13 of the top-15 life science companies and more than 50 other suppliers, totaling $200 billion in annual US commerce. IntegriChain is backed by Accel-KKR, a leading Silicon Valley technology private equity firm. For more information, visit www.integrichain.com and our blog, and follow us on Twitter @IntegriChain and LinkedIn.
IntegriChain is a registered trademark of IntegriChain Incorporated. All other trademarks are property of their respective owners.
Contact Jennifer Guinan | Sage Strategic Marketing | 610.410.8111 | Jennifer@sagestrat.com
Save the date!
Webinars & Resources
See List
